IAMA Therapeutics

📍 Genova, Italy🗓 Founded 2021👥 4 employees💰 Last funded Jan 2022
Pharmaceutical Manufacturing🌐 iamatherapeutics.com
Website LinkedIn
IAMA Therapeutics is a preclinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel medicines to make a difference in the lives of children and adults suffering from neurodevelopmental and cognitive disorders. IAMA Therapeutics couples emerging advances in drug discovery and neurobiology to build a leading, next-generation neuroscience pipeline to selectively inhibit the sodium-potassium chloride cotransporter and other therapeutic targets relevant to brain disorders characterized by neuronal imbalance. The company's preclinical pipeline consists of the lead candidate IAMA-6 for the treatment of idiopathic autism, IAMA-097 for the treatment of secondary autism, and other compounds for the treatment of refractory epilepsy and other brain disorders. IAMA-6 is a preclinical stage, a first-in-class selective-NKCC1 inhibitor that modulates the intracellular chloride, reducing the depolarizing strength of GABAA receptors to the levels required to restore the inhibitory transmission. This pathway is reported in Down syndrome, autism spectrum disorder, epilepsy, and other brain disorders characterized by increased intracellular chloride and depolarizing GABAergic transmission.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in IAMA Therapeutics?
IAMA Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did IAMA Therapeutics last raise funding?
The most recent investment in IAMA Therapeutics recorded on gritt.io was in January 2022.
When was IAMA Therapeutics founded?
IAMA Therapeutics was founded in 2021.
What industry is IAMA Therapeutics in?
IAMA Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is IAMA Therapeutics based?
IAMA Therapeutics is headquartered in Genova, Italy.